TRUEGLUE
Live / Applied — Third extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 19 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98004930
- Mark type
- Stylized text
- Filed
- 19 May 2023
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Tania A. Shapiro-Barr
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical substances for treatment of cardiovascular disease, cancer, and immune disorders by inducing interactions between biomolecules, such as proteins
Owner
- Magnet Biomedicine, Inc., Boston, MA, US
- Magnet Biomedicine, Inc., Boston, MA, US
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 3 GRANTED
- 12 Nov 2025 — SOU EXTENSION 3 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 May 2025 — SOU EXTENSION 2 GRANTED
- 30 May 2025 — SOU EXTENSION 2 FILED
- 30 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2024 — SOU EXTENSION 1 GRANTED
- 02 Dec 2024 — SOU EXTENSION 1 FILED
- 02 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2024 — PUBLISHED FOR OPPOSITION